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A 1-month-old male flat-coated retriever was anaesthetized for correction of oesophageal constriction caused by a vascular ring
anomaly. Anaesthesia was uneventfully induced with intravenous fentanyl, diazepam, and propofol andmaintained with isoflurane
in oxygen and air. An intercostal block with bupivacaine and lidocaine was performed, and additional analgesia with an infusion
of fentanyl was provided. Fluid therapy consisted in 5% glucose in lactated Ringer’s solution and hetastarch 6%, which proved
adequate to maintain normoglycemia and normovolemia. A lateral thoracotomy was performed, and the ligamentum arteriosum
was ligated. Intraoperatively, heart rate (HR) varied between 120 and 180 beatsmin−1 without accompanying changes in blood
pressure. No arrhythmias were observed or bleeding occurred. The dog recovered uneventfully. Postoperative analgesia consisted
in fentanyl infusion adjusted to the patient’s requirement and metamizol. This paper describes for the first time the use of balanced
anaesthesia and multimodal analgesia in a paediatric dog undergoing thoracotomy.
1. Introduction
Literature about paediatric patients in veterinary medicine
does not provide concise data regarding the development
of physiological important parameters for anaesthesia. Dogs
until 12 weeks old are considered paediatric patients and
are characterized by organ immaturity thus having a unique
physiology and pharmacology [1]. In these patients, the
gluconeogenesis and glycogenolysis are only partially acti-
vated, and the glucose storage capacity of the liver is less for
body weight than in adults [2]. Thus, plasma glucose levels
in puppies should be closely monitored during anaesthesia
[1, 2].
Nonshivering thermogenesis and thermal vasoconstric-
tion are active in paediatric patients; however, heat loss
is enhanced by the low subcutaneous fat reserves and the
increased surface area/weight ratio [3, 4]. These active
thermoregulatory responses are inhibited by anaesthetic
agents [4]. Thus, puppies undergoing anaesthesia should be
actively warmed to minimize temperature losses [3].
The sympathetic and parasympathetic systems in dogs
become fully functional by about 7 weeks of age [5]. It
has been seen in rats that positive inotropic responses to
sympathetic nerve stimulation first develop between 2 and 3
weeks of age [6]. As cardiac innervations are not functionally
mature in neonates, puppies may react only moderately to
sympathetic stimulation [6].
The hepatorenal system of neonatal dogs continues to
develop until 3 to 6 weeks of age [7], the hepatic enzymes
responsible for biotransformation are immature, and the
glomerular filtration rate is decreased [8]. The composition
of water in paediatric patients is higher than that in adults,
and the concentration of plasma proteins to bind drugs is
reduced [8]. Thus, clearance, metabolism, and excretion of
many drugs may be reduced and the dosing and dosing
intervals may be altered [7].
To correct vascular ring anomalies in veterinary med-
icine, thoracotomy is performed [9–12]. To avoid lung atelec-
tasis during these procedures, control of the ventilation is
necessary. In paediatric patients, lung protective mechanisms
should be used; the chest wall is highly compliant and
presents minimal elastic recoil, which can end in airway
collapse while in normal tidal breathing during anaesthesia,
and, therefore, ventilation needs to be assisted [13]. More-
over, thoracotomy-related pain is considered in adults to be
the most intense possible [13]. In infants, transduction from
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polymodal nociceptors is functional, and central nociceptive
processing develops gradually after birth [8, 14]. Thus,
adequate pain management should be provided in paediatric
patients [15].
In this paper, we describe for the first time the use of
balanced anaesthesia to preserve physiological stability while
providing adequate analgesia in a paediatric dog undergoing
thoracotomy for vascular ring anomaly correction.
2. Case Description
A 1-month-old male flat-coated retriever weighing 4.6 kg
was presented with retching and swallowing problems. The
dog was alert and showed normal quiet and calm behaviour.
Haematology and serum biochemical analysis were within
normal limits. A radiologic examination of the thoracic and
abdominal cavity was carried out including esophagography.
A presumptive diagnosis was made as persistent right
aortic arch (PRAA) on the basis of the anamnesis, clinical
signs, radiographic examination, and the esophagography.
The diagnosis was confirmed surgically as PRAA with left
ligamentum arteriosum (LA) and an aberrant left subclavian
artery (SA).
Preanaesthetic examination revealed a heart rate (HR) of
180 beatsmin−1, respiratory rate (RR) of 40 breathsmin−1,
pink mucous membranes, capillary filling time of 2 seconds,
and temperature of 38.4 degrees. The dog was deprived of
food for 6 hours without water restriction. The right cephalic
vein of the dog was catheterized using a 22-gauge-over-
needle peripheral catheter (Surflo catheter, Terumo, Leuven,
Belgium). Preoxygenation was performed with a mask dur-
ing 5 minutes. Coinduction of anaesthesia consisted on the
intravenous administration of fentanyl (Sintenyl, Sintetica
AG, Mendrisio, Switzerland) (5mcg kg−1), diazepam (Val-
ium, Roche Pharma, Reinach, Switzerland) (0.1mg kg−1),
and propofol (Propofol, Fresenius kabi AG, Stans, Switzer-
land) to effect. After intubation of the trachea, the cuffed
endotracheal tube (Athlone, Hi-contour, Mallinckrodt, Ire-
land) (6mm ID) was connected to an anaesthesia machine
(Megamed 700, Megamed AG, Cham, Switzerland) using a
small circle system (Intersurgical, United Kingdom) with a
heat and moisture exchanger (Hygrobaby, Mallinckrodt dar,
Tyco, Mirandola, Italy).
Anaesthesia was maintained with isoflurane (Isoflo,
Provet, Lyssach, Switzerland) in oxygen (0.2 Lmin−1) and
air (0.2 Lmin−1) resulting in an inspiratory fraction of
oxygen (FiO2) of 0.6. The dog was mechanically ventilated
(20 breathsmin−1) using intermittent positive pressure ven-
tilation (IPPV) volume controlled (tidal volume (VT) =
10mL kg−1), pressure limited (peak inspiratory pressure
(PIP) = 12mmHg) with a respiratory rate setting tomaintain
normocapnia (end-tidal carbon dioxide (EtCO2) = 6 kPa
(45mmHg)). Positive end expiratory pressure (PEEP =
3mmHg) was applied when the thoracic cavity was
open. The isoflurane concentration (end-tidal concentration
(ETiso) 1.1 to 1.4%) was adjusted to maintain an appropriate
anaesthesia depth judged by the position of the ocular globe,
evaluation of the palpebral reflex, and the breathing pattern.
Intraoperative pain management consisted of a fen-
tanyl infusion (10mcg kg−1 h−1) and desensitising the third
to the fifth intercostal nerves with 0.5mg kg−1 bupiva-
caine (Carbostesin 0.5%, Astra Zeneca, Zug, Switzerland)
and 1mg kg−1 lidocaine (Lidocaine 2%, Kantonsapotheke,
Zurich, Switzerland) as described by Gaynor andMama [16].
Fluid therapy consisted of 5% glucose (Glucose 50%,
Kantonsapotheke, Zurich, Switzerland) in lactated Ringer’s
solution (Ringer Laktat, Fresenius kabi AG, Stans, Switzer-
land) (8mL kg−1 h−1) and hetastarch 6% (Haes 6%, Frese-
nius kabi AG, Stans, Switzerland) (2mL kg−1 h−1). Glucose
plasma levels were measured every 30 minutes, and sup-
plementation aimed at glucose blood values between 5 and
9mmol L−1 (Table 1).
Heat loss was prevented with the help of an active air
warming device (Bair Hugger, Carbamed, Zurich, Switzer-
land), a heating blanket (Solis, Zug, Switzerland), and a heat
and moisture exchanger.
Monitoring of cardiovascular function consisted of the
evaluation of a constantly displayed ECG and oscillometric
measurements of indirect arterial blood pressures over an
antebrachial artery. The FiO2, RR, Etiso, and EtCO2 were
permanently obtained using a sidestream probe connected at
the Y-piece of the breathing system. The haemoglobin oxygen
saturation (SpO2) was evaluated by placing a pulse oximeter
probe on the tongue, and body temperature was monitored
using a thermometer placed in the oesophagus. All above-
mentioned parameters were obtained with a multiparameter
monitor (Cardiocap, Datex Ohmeda, Helsinki, Finland) and
recorded every 5 minutes.
A total of 6mg kg−1 IV propofol were necessary to
induce anaesthesia. No regurgitation occurred. The surgical
approach consisted in a left lateral thoracotomy at the level
of the 4th intercostal space. Intraoperative antibiotherapy
consisted of cefazolin (Kefzol, Teva Pharma AG, Aesch,
Switzerland) (22mg kg−1 IV) and metronidazole (Metron-
idazole, B.Braun, Sepmbach, Switzerland) (10mg kg−1 IV).
Cardiovascular parameters are represented in Figure 1.
Mean arterial blood pressure ranged from 58 to 70mmHg
during maintenance of anaesthesia. Heart rate decreased
from 180 beatsmin−1 to 120 beatsmin−1 in the first
hour. Following opening of the thoracic cavity, during the
following 110 minutes, HR varied between 120 and 180
beatsmin−1. When the thorax closure started, heart rate
decreased and remained between 100 and 140 beatsmin−1
until the end of anaesthesia. No arrhythmias were observed.
The capillary refill time was always 2 seconds, and the
mucous membranes were pink. The SpO2 during mainte-
nance of anaesthesia was 96–99%. Temperature increased
over time from 36.2 to 38.1 degrees centigrade. During
surgery, the LA was ligated and transected without manip-
ulation of the aberrant left SA. The oesophagus did not
present any macroscopic lesions. A tube gastrostomy was
also performed. Total anaesthesia time was 3 hours and 30
minutes.
For recovery of anaesthesia, isoflurane was discontinued,
the trachea was extubated, and the dog was transferred to a
warm and padded cage at the intensive care unit. Continuous
ECG was monitored during the following 24 hours, and no
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Table 1: Glucose values from a dog during anaesthesia for ring anomaly correction. The samples were obtained every 30 minutes
corresponding to beginning of maintenance of anaesthesia (T0 h), minute 30 (T0.5 h), 60 (T1 h), 90 (T1.5 h), 120 (T2 h), 150 (T2.5 h),
180 (T3 h), and 210 (T3.5 h).
T0 h T0.5 h T1 h T1.5 h T2 h T2.5 h T3 h T3.5 h
Glucose (mmol L−1) 5.4 5.4 5.8 6.4 7.6 8.8 8.9 9.1
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Figure 1: Noninvasive mean arterial blood pressure (mean BP,
mmHg) and heart rate (HR, beatsmin−1) during maintenance of
anaesthesia of a dog undergoing surgery for vascular ring anomaly
correction. The beginning and the end of surgery are marked with
an asterisk (∗). The beginning and the end of the intraoperative
period during which the heart was manipulated are marked with
arrows.
arrhythmias were observed. Fluid therapy consisted in 5%
glucose in lactated Ringer’s solution (2mL kg−1 h−1) and was
given for five days after surgery. During this period, post-
operative analgesia was provided with 2–10mcg kg−1 h−1
fentanyl IV. The fentanyl dose was adjusted to the patient
requirements. On day 6, fentanyl was discontinued, and
metamizol (Novalgin, Veterinaria AG, Pfa¨ffikon, Switzer-
land) (30mg kg−1 IV tid) was administered for a week.
Further antibiotherapy with cefazolin (22mg kg−1 IV tid)
was administered during 2 weeks. The gastrostomy tube
was removed 2 weeks after surgery, and the patient was
discharged from the hospital.
3. Discussion
To the author’s knowledge, there is scarce information
regarding anaesthetic techniques for thoracotomy in pup-
pies, and this is the first paper in which a balanced anaes-
thetic technique and a multimodal analgesic approach are
described in a 1-month-old dog undergoing thoracotomy for
vascular ring anomaly correction.
One main concern during induction of anaesthesia
was the risk of aspiration pneumonia after regurgitation
secondary to megaesophagus [1]. Propofol, a fast-acting
induction agent, was chosen because it abolishes quickly
the swallowing reflex and intubation of the trachea can
be rapidly performed [17]. However, propofol impairs
cardiovascular function in a dose-dependent manner and
a reduction of the dose is desirable. Therefore, fentanyl
and diazepam were coadministered as it has been shown in
adult dogs to reduce the requirements of propofol necessary
for induction of anaesthesia [18]. As fentanyl, diazepam,
and the soya-oil-based propofol used are lipid soluble, the
higher body water content of the puppy was expected to
minimally influence the distribution of the drug; for this
reason we decided to use dosing described for adult dogs
[7]. Extrapolating from human data, clearance of these
drugs was not expected to be delayed in this puppy. Indeed,
the major metabolic pathway of fentanyl and propofol,
glucuronidation, reaches adult rates by the first year of life.
In addition, hepatic hydroxylation in neonates is active and
fully contributes to a rapid drug clearance [19]. There is
also evidence that the CYP3A4 enzyme, responsible for the
hepatic metabolism of diazepam, appears during the first
week of life [20]. Propylene glycol, the excipient of the com-
mercially available formulation of diazepam, is only partially
metabolized in the liver and excreted up to 45% unchanged
in the urine [21]. It could be speculated that elimination
of propylene glycol may have been delayed as glomerular
filtration rate is reduced in puppies [8] and a formulation of a
benzodiazepine without propylene glycol such as midazolam
could be a better option; however, the LD50 of this adjuvant
has been reported to be at volumes of 9mL kg−1, a volume
100 times above the one administered to this puppy [22].
Severe pain is accompanying thoracotomies [23].
Although information in puppies is missing, human data
showed that nociception in the neonate is facilitated as both
A and C fibers activate spinal pathways. Central nociceptive
pathways, including spinothalamic and cortical fibers,
are functional, and the descending inhibitory pathways
are delayed although responsive [7, 15, 24]. Hence, it
was decided to combine lidocaine and bupivacaine to
provide local analgesia at the surgical side in combination
with a fentanyl CRI. This multimodal approach has
been proven to provide adequate analgesia during and
following thoracotomy in dogs [25, 26]. These amino amide
local anaesthetic agents are metabolized in the hepatic
microsomes via dealkylation, hydrolyzed, and excreted in the
urine [8]. As dealkylation activity in neonates is close to the
adult pattern [27], it was speculated that their elimination
would be appropriate.
Fentanyl was chosen as part of the multimodal approach
in this puppy as it is a potent analgesic recommended for
severe pain relief in dogs [7]. Opioid receptors have been
found in humans and laboratory animals to be present
since birth, suffering reorganisation over time [24]. Advanta-
geously, fentanyl has an increased volume of distribution in
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children [19]. This may contribute to the reduced degree of
respiratory depression seen in neonates after administration
of 10mcg kg−1 IV fentanyl [28]. However, neonates are more
sensitive to the depressant effects of opioids because the
blood-brain barrier is immature [19]. This puppy received
fentanyl infusion intra- and postoperatively, and side effects
described in children due to opioids administration such
as respiratory depression, apathy, nausea, ileus, urinary
retention, or itching were not observed [8]. A prolonged
effect of fentanyl due to reduced clearance of the drug may
have occurred in our puppy [19]; six days following thora-
cotomy, the pain management of the puppy was reduced to
metamizol. As opioid tolerance can occur in children [29],
the fentanyl dose rate administered postoperatively to our
puppy was decreased according to the patient requirements.
In this puppy, variations in HR were observed during
intrathoracic surgical manipulations. This was considered
a compensatory mechanism to reduced venous return sec-
ondary to compression of the vena cava or other thoracic
vessels. As puppies have a highly compliant chest wall, it
might be easier to compress the organs in the thoracic cavity
[13]. However, maturation of the baroreflex in dogs occurs
with growth from 1 week to 6 months [30]. Therefore, this
reflex may have been immature in this 4-week-old puppy
[1, 6]. Changes in mean blood pressure did not accompany
increases in HR. This could be explained by a slower
maturation of alpha adrenergic receptors in the vascular
smooth muscle, which regulate and maintain vascular tone
[31].
Increases in HR could also be interpreted as inadequate
analgesia provision or even awareness. It is possible that
the intercostal blocks failed because the technique was not
performed adequately or because mixing lidocaine (with fast
onset and intermediate duration, 1-2 hs) and bupivacaine
(with long onset and duration of action, 3–10 hs) provides
unpredictable analgesic effects due to changes in baricity and
pH [32].
Adjunctive analgesia, such as the continuous administra-
tion of lidocaine, would probably have allowed a reduction
in the dose of fentanyl and isoflurane as well as the
concurrent prevention of ventricular arrhythmia-associated
direct manipulation around the heart. Lidocaine decreases
automaticity of the heart by blocking sodium channels, and
this effect in a paediatric patient could have resulted in a
decreased cardiac output [6, 33]. Therefore, the use of intra-
venous lidocaine in this paediatric patient was disregarded
because a potential decrease in its metabolic clearance would
have resulted in drug accumulation. In addition, the reduced
concentration of the plasma α1-acid glycoproteins observed
in paediatric patients would hypothetically lead to potential
toxic concentrations of unbound lidocaine that could cause
seizures and cardiac depression [8].
Multimodal analgesia could have been improved with
nonsteroidal anti-inflammatory drugs (NSAIDs). The
cyclooxygenase (COX) enzyme oxidizes arachidonic acid to
eicosanoids, including prostaglandins, which are synthesized
at constant rate (not stored) and facilitate physiological
functions such as generation of the mucosal defences,
correct platelet function, leukocyte adherence, and renal
protection, and maturation [34]. The NSAIDs inhibit the
COX enzymes, and their use is restricted to well-hydrated
and normotensive patients older than 6 weeks [35]. For this
reason, NSAIDs were not administered in this puppy.
This patient received for postoperative pain management
metamizol instead. Metamizol has been classified by some
authors as antipyretic drug that provides smooth muscle
relaxation and spasmolysis [36]. Metamizol, however, could
have been deleterious in this patient as it may cause neu-
tropenia, leukopenia, agranulocytosis, and aplastic anemia,
all of which have been described in children [37–39].
However, evidence in dogs demonstrating these side effects
is missing, and no side effects were observed in this puppy.
“Low stretch” ventilation strategies were used in this
puppy aiming at providing lung protection [40]. The PIP was
limited to 12mmHg and theVT was lower (10mL kg−1) than
that reported for adult dogs (VT = 16mL kg−1 [41]). This
strategy may be advantageous in children as it decreases the
work of breathing [13]. Children have a lower proportion
of diaphragm fatigue-resistant fibers, and the functional
residual capacity is near to the alveolar closing volume [8].
The situation is worsened when intercostal muscle tone is
decreased by induction of anaesthesia [13]. The PEEP used
in this puppy was the lowest to avoid visible lung collapse.
Hepatic glucose production and storage are immature in
paediatric patients, gluconeogenic enzymes to convert amino
acids to glucose are inefficient, and hepatic glucose release is
decreased as the glycogen phosphorylase and the glucose-6
phosphatase enzymes are not fully active [2].
Transient hypoglycaemia has been associated with neu-
rologic injury in neonates, while hyperglycaemia can induce
osmotic diuresis and, consequently, dehydration and elec-
trolyte disturbances [42]. Lactated Ringer’s solution was
supplemented with 5% glucose because it has been shown
in human paediatric anaesthesia patients to decrease the
incidence of hypoglycaemia, without significantly affecting
the incidence of hyperglycemia [42]. In dogs, a 5% glucose
infusion has been suggested to maintain normoglycemia
during anaesthesia [43].
Severe complications can result from hypothermia such
as impaired coagulation and platelet function, reduced
immune function, and prolonged recovery [44]. Strategies
to actively warm the puppy were applied during anaesthesia
because, in addition to low subcutaneous reserves, the
vasodilation caused by isoflurane would facilitate further
heat loss [45]. The body surface was maintained warm
using a heating pad and a forced hot air device, while
the heat losses due to humidifying and heating inspiratory
gases were minimized using a heat and moisture exchanger.
These strategies proved to be effective because, despite
temperature decreased during preparation of the surgical
field, it increased over time.
The combination of PRAA with left LA and aberrant
left SA is a rare vascular ring anomaly, which causes
oesophageal stenosis and needs surgical correction [46].
Luckily, the major complications reported during surgery,
namely, acute bleeding or life-threatening arrhythmias sec-
ondary to manipulations, did not occur in this puppy.
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4. Conclusion
This paper describes a multimodal anaesthetic and analgesic
approach using intercostal blocks and a fentanyl infusion
to minimize intraoperative nociception in a paediatric dog
undergoing thoracotomy.
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